相关实验视频
Updated: Jun 20, 2026

14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 5, 2010
梅波利祖马布在严重不受控制的CRSwNP中:意大利东北部的一项现实生活多中心研究
G Ottaviano1, G Roccuzzo1, T Saccardo1
1Department of Neurosciences, Otolaryngology Section, University of Padova, Padova, Italy.
Rhinology
|April 18, 2025
概括
梅波利祖马布有效治疗严重的鼻多性慢性鼻炎 (CRSwNP),改善鼻腔阻塞和气味等症状. 这项现实研究证实了它对已经使用鼻内皮质类固醇的患者的好处.
科学领域:
- 免疫学 免疫学 免疫学
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
- 药理学 药理学是指药理学的学科.
背景情况:
- 严重的,不受控制的带鼻多的慢性鼻炎 (CRSwNP) 显著影响生活质量.
- 目前的治疗方法,包括鼻内皮质类固醇,可能对所有患者来说都不够.
- 梅波利祖马布是一种生物药物,其向的目标是埃索诺菲尔炎症.
研究的目的:
- 评估梅波利祖马布作为严重CRSwNP的补充疗法的现实有效性.
- 评估意大利东北部Triveneto地区接受治疗的患者的治疗结果.
- 分析患者和医生报告的结果和客观措施.
主要方法:
- 一项前性,现实研究,涉及90名患有严重CRSwNP的患者.
- 患者除了鼻内皮质类固醇外,还接受了梅波利祖马布.
- 结果被评估在多个时间点,长达12个月,使用验证的问卷,鼻内镜和客观测试.
主要成果:
- 在一个月内,鼻腔阻塞,气味和整体生活质量明显改善.
- 这些好处在整个12个月的随访期内持续存在.
- 梅波利祖马布的耐受性一般很好,没有报告重大不良事件,由于缺乏疗效而导致停药率低.
结论:
- 梅波利祖马布是一种有效的治疗方法,可以改善严重CRSwNP的关键症状.
- 这项研究支持mepolizumab在这个患者群体的实际临床实践中使用.
- 梅波利祖马布为患有持续性CRSwNP症状的患者提供了一种有价值的治疗选择.
相关概念视频
COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Asthma III: Clinical Manifestations
Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
